Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedAdvisor Limited ( (AU:AHE) ) just unveiled an announcement.
Adheris Health Limited has notified the market of the issue of 60 million unquoted options under an employee incentive scheme. The options, which are not intended to be quoted on the ASX, carry an exercise price of $0.03 and expire on 30 June 2035, indicating a significant long-term equity-based compensation initiative for staff and potential future dilution for existing shareholders.
The issuance of these options suggests the company is using equity incentives to align employee interests with long-term performance and shareholder value. This sizeable grant may help Adheris Health attract and retain key personnel in a competitive healthcare market while signaling management’s confidence in the company’s prospects over the next decade.
The most recent analyst rating on (AU:AHE) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited, listed on the ASX under the code AHE, operates in the healthcare sector. The company focuses on health-related services, though the announcement provides no further detail on its specific products or market segment.
Average Trading Volume: 490,002
Technical Sentiment Signal: Sell
Current Market Cap: A$12.74M
For detailed information about AHE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “…Supporting the Responsible Growth of our Industry…” Boeing Stock (NYSE:BA) Notches Up With Carbon Purchase
- “Secure Foundations for the Era of Frontier AI”: Microsoft Stock (NASDAQ:MSFT) Gains With New AI Plans
- Elon Musk Made $158 Billion in 2025, But Received None of It. Tesla Stock (NASDAQ:TSLA) Surges

